Beijing Meizhong Airui Tumor Hospital

Beijing Meizhong Airui Tumor Hospital is a China-based tertiary oncology specialty hospital focused on comprehensive cancer diagnosis, treatment, and rehabilitation. The hospital operates under the Meizhong Yihe (Amcare) medical group and emphasizes a real-time tiered MDT model across major tumor types including lung, breast, gynecologic, gastrointestinal, hepatobiliary, urologic, hematologic, thyroid, and neurologic tumors. In addition to routine oncology care, it has developed capabilities in radiotherapy, imaging, pathology, rehabilitation, and clinical research, and it has been described as having drug clinical trial institution filing status. The hospital also participates in translational and cell therapy-related collaborations, including work connected to CAR-T and TIL exploration through the broader Amcare research platform. Overall, it is best characterized as a commercial oncology care provider and research-enabled hospital rather than a drug-development biotech company.